NCT00269815View on ClinicalTrials.gov

Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity Disorder

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Study Completion Date

December 31, 1999

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

methylphenidate HCl

All Listed Sponsors

lead

Alza Corporation, DE, USA

INDUSTRY

NCT00269815 - Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity Disorder | Biotech Hunter | Biotech Hunter